http://www.unboundmedicine.com/medline/ebm/research/abacavirUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19891054/full_citation/Changes_in_biomarkers_of_cardiovascular_risk_after_a_switch_to_abacavir_in_HIV_1_infected_individuals_receiving_combination_antiretroviral_therapy_Kristoffersen US, Kofoed K, Kronborg G, et al. 
Changes in biomarkers of cardiovascular risk after a switch to abacavir in HIV-1-infected individuals receiving combination antiretroviral therapy. [Journal Article, Research Support, Non-U.S. Gov't]
HIV Med 2009 Nov; 10(10):627-33.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19878352/full_citation/PENTA_2009_guidelines_for_the_use_of_antiretroviral_therapy_in_paediatric_HIV_1_infection_ 
PENTA 2009 guidelines for the use of antiretroviral therapy in paediatric HIV-1 infection. [Journal Article]
HIV Med 2009 Nov; 10(10):591-613.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19863618/full_citation/Implementing_the_number_needed_to_harm_in_clinical_practice:_risk_of_myocardial_infarction_in_HIV_1_infected_patients_treated_with_abacavir_Kowalska J, Kirk O, Mocroft A, et al. 
Implementing the number needed to harm in clinical practice: risk of myocardial infarction in HIV-1-infected patients treated with abacavir. [JOURNAL ARTICLE]
HIV Med 2009 Oct 27.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19843279/full_citation/Successful_implementation_of_a_national_HLA_B_5701_genetic_testing_service_in_Canada_Lalonde RG, Thomas R, Rachlis A, et al. 
Successful implementation of a national HLA-B*5701 genetic testing service in Canada. [JOURNAL ARTICLE]
Tissue Antigens 2009 Oct 15.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19842973/full_citation/Simplification_of_Antiretroviral_Therapy_with_Tenofovir_Emtricitabine_or_Abacavir_Lamivudine:_A_Randomized_96_Week_Trial_Martin A, Bloch M, Amin J, et al. 
Simplification of Antiretroviral Therapy with Tenofovir-Emtricitabine or Abacavir-Lamivudine: A Randomized, 96-Week Trial. [JOURNAL ARTICLE]
Clin Infect Dis 2009 Oct 20.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19839743/full_citation/A_Study_of_HIV_Provider_Attitudes_Toward_HLA_B_5701_Testing_in_the_United_States_Watson ME, Patel LG, Ha B, et al. 
A Study of HIV Provider Attitudes Toward HLA-B*5701 Testing in the United States. [JOURNAL ARTICLE]
AIDS Patient Care STDS 2009 Oct 19.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19838086/full_citation/[Efficacy_and_safety_of_TAM_sparing_antiretroviral_regimens_in_nave_HIV_positive_patients_]Gottardi M, Lanzafame M, Lattuada E, et al. 
[Efficacy and safety of TAM-sparing antiretroviral regimens in na?ve HIV-positive patients.] [JOURNAL ARTICLE]
Infez Med 2009 Sep 1; 17(3):151-158.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19835489/full_citation/Voriconazole_use_and_pharmacokinetics_in_combination_with_interferon_gamma_for_refractory_cryptococcal_meningitis_in_a_patient_receiving_low_dose_ritonavir_Nierenberg NE, Thompson GR, Lewis JS, et al. 
Voriconazole use and pharmacokinetics in combination with interferon-gamma for refractory cryptococcal meningitis in a patient receiving low-dose ritonavir. [JOURNAL ARTICLE]
Med Mycol 2009 Oct 19.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19798416/full_citation/Drugs_associated_with_more_suicidal_ideations_are_also_associated_with_more_suicide_attempts_Robertson HT, Allison DB 
Drugs associated with more suicidal ideations are also associated with more suicide attempts. [Journal Article, Research Support, N.I.H., Extramural]
PLoS One 2009; 4(10):e7312.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19785663/full_citation/Effects_of_nucleoside_reverse_transcriptase_inhibitor_backbone_on_the_efficacy_of_first_line_boosted_highly_active_antiretroviral_therapy_based_on_protease_inhibitors:_meta_regression_analysis_of_12_clinical_trials_in_5168_patients_Hill A, Sawyer W 
Effects of nucleoside reverse transcriptase inhibitor backbone on the efficacy of first-line boosted highly active antiretroviral therapy based on protease inhibitors: meta-regression analysis of 12 clinical trials in 5168 patients. [Journal Article]
HIV Med 2009 Oct; 10(9):527-35.
Abstract | Full Citation | Find Related Articles